Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)

Table 1 Schedule of trial interventions and assessments

Time points	Immediate entry		Deferred entry
Time points	Patient^a	Surrogate	Patient^a	Surrogate
T1 Baseline	IST 15 CORE 34 KDQOL-36™ SHARED	ACP agreement questionnaire	IST 15 CORE 34 KDQOL-36™ SHARED
T1 Baseline	ACP intervention	ACP intervention	IST 15 CORE 34 KDQOL-36™ SHARED
T2 2/52	ACP 1st review^b CORE 34 SHARED	ACP agreement questionnaire before review	CORE 34 SHARED
T3 12/52	ACP 2nd review^b CORE 34 KDQOL-36™ SHARED	ACP agreement questionnaire after review	CORE 34 KDQOL-36™ SHARED	ACP agreement questionnaire
T3 12/52	ACP 2nd review^b CORE 34 KDQOL-36™ SHARED	ACP agreement questionnaire after review	ACP intervention	ACP intervention
T4 24/52			ACP review^b CORE 34 KDQOL-36™ SHARED	ACP agreement questionnaire after review

IST 15 Isaacs Set Test, CORE 34 Clinical Outcomes in Routine Evaluation measure, KDQOL-36™ Kidney Disease Quality of Life instrument – Short Form, SHARED Patient Experience of Shared Decision Making instrument
^aPatients in both groups also completed a cost diary during intervention period as part of the economic evaluation
^bSurrogate may not be at the review of the ACP with the patient (this is at the patient and/or surrogate’s discretion)

ISSN: 1471-2369